Blog
RSS FeedPosted by Michael Wonder on 29 Jan 2017
Sunovion’s Latuda (lurasidone hydrochloride) receives FDA approval to treat adolescents with schizophrenia
28 January 2017 - First treatment approved in five years for adolescents aged 13-17 years with schizophrenia. ...
Posted by Michael Wonder on 29 Jan 2017
The GOP grapples with creating a better Obamacare
27 January 2017 - After spending much of the past seven years trying to repeal Obamacare, Republicans in Congress finally ...
Posted by Michael Wonder on 28 Jan 2017
Behind closed doors, Republicans fret about how to repeal Obamacare
28 January 2017 - Republican lawmakers aired sharp concerns about their party's quick push to repeal the Affordable Care Act ...
Posted by Michael Wonder on 28 Jan 2017
Days before a deadline, Trump team cancels ads for Obama health plan
26 January 2017 - The Trump administration is pulling back advertisements that encourage people to sign up for health insurance ...
Posted by Michael Wonder on 26 Jan 2017
Biogen sees gradual Spinraza launch, eyes mid-year EU approval
26 January 2017 - Biogen Inc said on Thursday that the first U.S. patients have received its new drug for ...
Posted by Michael Wonder on 26 Jan 2017
Tom Price cracks the drug-price negotiation door
26 January 2017 - The Senate finance committee's grilling this week of Tom Price, President Trump's nominee to head the Department ...
Posted by Michael Wonder on 26 Jan 2017
Republicans lay out plans for Obamacare repeal
26 January 2017 - U.S. Republican leaders on Wednesday laid out plans for repealing Obamacare by spring, followed by funding ...
Posted by Michael Wonder on 26 Jan 2017
U.S. FDA approves 72 mcg dose of Linzess (linaclotide) for adults with chronic idiopathic constipation
26 January 2017 - New dosage strength expected to be available in first quarter of 2017. ...
Posted by Michael Wonder on 26 Jan 2017
Narcan (naloxone hydrochloride) 2 mg nasal spray approved by FDA
25 January 2017 - Adapt Pharma to provide 2 mg as an additional dosing option for naloxone nasal spray ...
Posted by Michael Wonder on 25 Jan 2017
AbbVie initiates phase 2 clinical trial programs for ABBV-8E12, an investigational anti-tau antibody, in early Alzheimer's disease and progressive supranuclear palsy
25 February 2017 - ABBV-8E12 granted fast track designation from the U.S. FDA for progressive supranuclear palsy. ...
Posted by Michael Wonder on 25 Jan 2017
Novartis says court battle will delay its Enbrel copy until 2018 at least
25 January 2017 - The Novartis copy of Amgen's blockbuster psoriasis drug Enbrel will not go on sale before 2018 ...
Posted by Michael Wonder on 25 Jan 2017
Tom Price’s heated hearing is unlikely to derail his nomination
24 January 2017 - In a heated confirmation hearing that focused on ethical issues, President Trump’s nominee for secretary of ...
Posted by Michael Wonder on 25 Jan 2017
Atlantic Healthcare receives FDA agreement to initiate rolling submission of its new drug application for alicaforsen in the treatment of pouchitis
24 January 2017 - FDA to accept sections of the regulatory application ahead of final Phase 3 data expected in ...
Posted by Michael Wonder on 24 Jan 2017
Roche says FDA grants priority review for Actemra
24 January 2017 - The U.S. FDA has granted priority review designation of Roche's rheumatoid arthritis medication Actemra for giant cell ...
Posted by Michael Wonder on 24 Jan 2017
Express Scripts, Cigna opt out of paying for EpiPen competitor Auvi-Q
23 January 2017 - It's unclear how much of the hefty $4,500 price pharmacy benefit managers or insurers will agree to ...